Zeo ScientifiX, Inc. (ZEOX)
Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company specializing in developing biological therapeutics aimed at treating degenerative diseases and fostering regenerative medicine. Its flagship investigational product, Zofin, is an acellular biologic therapy sourced from perinatal materials. This candidate is currently in Phase I/II clinical trials, evaluating its efficacy for COVID-19, chronic obstructive pulmonary disease (COPD), and knee osteoarthritis. The company's portfolio also includes Patient Pure X, an autologous, blood-derived biologic technology designed to enhance the body's natural capacity to reduce cellular inflammation and promote tissue healing. Furthermore, Zeo ScientifiX develops and distributes products containing its proprietary ingredients for topical aesthetic applications. These offerings include ZEO GROW X, a professional-grade formula delivering concentrated topical exosomes to support follicular function, as well as ZEO GROW BOOST and EXO FOLLICLE FUEL. Founded in 2011, the company was formerly known as Organicell Regenerative Medicine, Inc. before rebranding to Zeo ScientifiX, Inc. in February 2024. It is headquartered in Davie, Florida.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Zeo ScientifiX, Inc.
OTC:ZEOXHealthcare · Biotechnology
+0.00%$1.36
Mkt Cap$10.66M
Float1.06M
O/S7.84M
Vol
$ Vol
RVOL
Inst Own-
SI<0.1%
Earnings
Dilution
Financials Summary
Revenue$5.2M
Net Income-$5.52M
Total Assets$1.53M
Free Cash Flow-$741K
Debt & Equity
Total Debt$353K
Total Equity-$1.42M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:2Reverse splitFeb 14, 20062 shares → 1
Balance Sheet Details
Assets$1.53M
Liabilities$2.95M
Accounts Receivable$35K
Accounts Payable$0
Inventory$423K
PP&E (Net)$569K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 | 2018-10-31 | 2017-10-31 | 2016-10-31 | 2015-10-31 | 2014-10-31 | 2013-10-31 | 2012-10-31 | 2011-10-31 |
| Revenue | $5.2M | $4.62M | $4.56M | $6.49M | $5.6M | $3.06M | $1.7M | $965K | $570K | $185K | $148K | $49K | $83K | $87K | $18K |
| YoY Growth | 12.5% | 1.4% | -29.8% | 16.0% | 83.2% | 79.5% | 76.5% | 69.3% | 208.2% | 25.2% | 200.1% | -40.7% | -4.8% | 382.0% | - |
| Cost of Revenue | $931K | $844K | $508K | $754K | $548K | $399K | $301K | $209K | $161K | $94K | $49K | $20K | $44K | $61K | $11K |
| Gross Profit | $4.27M | $3.78M | $4.05M | $5.74M | $5.05M | $2.66M | $1.4M | $755K | $409K | $90K | $98K | $29K | $39K | $26K | $7K |
| Gross Margin | 82.1% | 81.7% | 88.9% | 88.4% | 90.2% | 87.0% | 82.3% | 78.3% | 71.8% | 48.9% | 66.5% | 59.2% | 46.4% | 29.9% | 39.2% |
| Research and Development | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $9.65M | $9.1M | $10.82M | $14.58M | $17.79M | $15.1M | $3.18M | $4.25M | $9.05M | $0 | $861K | $95K | $71K | $38K | $19K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.13M | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $9.65M | $9.1M | $10.82M | $14.58M | $17.79M | $15.1M | $3.18M | $4.25M | $9.05M | $1.13M | $861K | $95K | $71K | $38K | $19K |
| Operating Income (EBIT) | -$5.39M | -$5.32M | -$6.77M | -$8.84M | -$12.74M | -$12.44M | -$1.78M | -$3.49M | -$8.64M | -$1.04M | -$763K | -$66K | -$32K | -$12K | -$12K |
| Operating Margin | -103.6% | -115.1% | -148.5% | -136.2% | -227.7% | -407.0% | -104.4% | -361.8% | -1516.5% | -564.3% | -516.8% | -133.8% | -38.8% | -14.2% | -64.9% |
| Interest Expense | $98K | $92K | $431K | $398K | $38K | $178K | $47K | $228K | $576K | $13K | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$135K | $614K | -$219K | -$54K | -$12K | -$112K | $38K | $59K | -$471K | -$13K | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax (EBT) | -$5.52M | -$4.71M | -$6.99M | -$8.9M | -$12.76M | -$12.55M | -$1.74M | -$3.43M | -$9.11M | -$1.06M | -$763K | -$66K | -$32K | -$12K | -$12K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $33K | $85K | $287K | -$105K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$5.52M | -$4.71M | -$6.99M | -$8.9M | -$12.76M | -$12.58M | -$1.74M | -$3.46M | -$8.97M | -$1.25M | -$738K | -$66K | -$32K | -$12K | -$12K |
| Net Income Margin | -106.2% | -101.8% | -153.3% | -137.1% | -227.9% | -411.8% | -102.1% | -358.9% | -1574.5% | -677.8% | -500.1% | -133.8% | -38.8% | -14.2% | -64.9% |
| Supplementary Data | |||||||||||||||
| EPS | -0.86 | -0.74 | -0.99 | -1.56 | -2.00 | -0.02 | -0.01 | -0.01 | -0.08 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Diluted EPS | -0.86 | -0.74 | -0.99 | -1.56 | -2.00 | -0.03 | -0.01 | -0.01 | -0.08 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Weighted Average OS | 6.41M | 6.34M | 7.03M | 5.69M | 5.30M | 476.53M | 271.81M | 271.81M | 108.60M | 100.38M | 150.12M | 150.12M | 143.45M | 135.00M | 135.00M |
| EBITDA | -$5.35M | -$4.54M | -$6.07M | -$8.17M | -$12.67M | -$12.37M | -$1.68M | -$3.23M | -$8.38M | -$1.24M | $86 | -$66K | -$32K | -$12K | -$12K |
| EBITDA Margin | -102.9% | -98.2% | -133.2% | -125.8% | -226.3% | -404.8% | -98.5% | -334.5% | -1470.0% | -670.8% | 0.1% | -133.8% | -38.8% | -14.2% | -64.9% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 | 2018-10-31 | 2017-10-31 | 2016-10-31 | 2015-10-31 | 2014-10-31 | 2013-10-31 | 2012-10-31 | 2011-10-31 |
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash and Cash Equivalents | $221K | $657K | $1.76M | $3.75M | $109K | $591K | $133K | $43K | $40K | $26K | $99K | $244 | $16K | $2K | $12K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $221K | $657K | $1.76M | $3.75M | $109K | $591K | $133K | $43K | $40K | $26K | $99K | $244 | $16K | $2K | $12K |
| Accounts Receivable | $35K | $197K | $30K | $191K | $104K | $29K | $26K | $48K | $115K | $1K | $20K | $0 | $0 | $0 | $0 |
| Inventory | $423K | $232K | $310K | $249K | $235K | $147K | $78K | $0 | $120K | $10K | $2K | $11K | $17K | $16K | $9K |
| Other Current Assets | $279K | $0 | $0 | $0 | $0 | $79K | $121K | $15K | $7K | $0 | $5K | $0 | $0 | $0 | $0 |
| Total Current Assets | $958K | $1.17M | $2.2M | $4.37M | $517K | $846K | $358K | $106K | $281K | $37K | $126K | $11K | $32K | $19K | $21K |
| Long-Term Assets | |||||||||||||||
| Property, Plant & Equipment Net | $569K | $478K | $573K | $1.79M | $1.37M | $471K | $263K | $6K | $53K | $28K | $8K | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $7K | $40K | $48K | $18K | $5K | $5K | $42K | $5K | $19K | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $569K | $478K | $580K | $1.83M | $1.42M | $488K | $268K | $11K | $96K | $33K | $26K | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.53M | $1.64M | $2.78M | $6.2M | $1.93M | $1.33M | $626K | $117K | $377K | $70K | $153K | $11K | $32K | $19K | $21K |
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payable | $0 | $0 | $0 | $2.38M | $1.87M | $766K | $552K | $477K | $592K | $249K | $105K | $2K | $21K | $19K | $7K |
| Short-Term Debt | $243K | $5K | $657K | $563K | $148K | $271K | $505K | $380K | $221K | $100K | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $598K | $884K | $497K | $0 | $10K | $0 | $0 | $22K | $84K | $0 | $15K | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $19K | $680K | $0 | $674K | $126K | $1.5M | $979K | $454K | $2.98M | $504K | $19K | $61K | $0 | $0 | $0 |
| Total Current Liabilities | $2.87M | $3.29M | $4.01M | $4.06M | $4.13M | $2.54M | $2.04M | $1.33M | $3.88M | $853K | $140K | $63K | $21K | $19K | $7K |
| Long-Term Liabilities | |||||||||||||||
| Long-Term Debt | $77K | $8K | $0 | $0 | $0 | $186K | -$186.41B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | -$1 | $0 | $0 | $186.41M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $77K | $8K | $13K | $249K | $472K | $186K | $153K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $1 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.95M | $3.3M | $4.02M | $4.31M | $4.6M | $2.73M | $2.19M | $1.33M | $3.88M | $853K | $140K | $63K | $21K | $19K | $7K |
| Stockholders' Equity | |||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $7K | $6K | $7K | $7K | $1.13M | $940K | $503K | $436K | $111K | $104K | $99K | $8K | $8K | $8K | $8K |
| Retained Earnings | -$67.73M | -$62.21M | -$57.51M | -$50.52M | -$41.62M | -$28.87M | -$16.29M | -$14.55M | -$11.09M | -$2.11M | -$860K | -$122K | -$56K | -$24K | -$12K |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | -$18K | -$3K | -$20K | -$431 | $0 | $3K | $573 | -$997 | $0 |
| Other Stockholders' Equity | $66.3M | $60.55M | $56.26M | $52.4M | $37.83M | $26.54M | $14.22M | $12.85M | $7.42M | $1.23M | $774K | $61K | $59K | - | $18K |
| Total Equity | -$1.42M | -$1.65M | -$1.24M | $1.89M | -$2.67M | -$1.39M | -$1.56M | -$1.26M | -$3.56M | -$783K | $13K | -$52K | $11K | $0 | $13K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.53M | $1.64M | $2.78M | $6.2M | $1.93M | $1.33M | $626K | $74K | $324K | $70K | $153K | $11K | $32K | $19K | $21K |
| Supplementary Data | |||||||||||||||
| Total Debt | $353K | $13K | $693K | $1.04M | $827K | $457K | -$186.41B | $380K | $221K | $100K | $0 | $0 | $0 | $0 | $0 |
| Net Debt | $132K | -$644K | -$1.06M | -$2.71M | $719K | -$134K | -$186.41M | $337K | $181K | $74K | -$99K | -$244 | -$16K | -$2K | -$12K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 | 2018-10-31 | 2017-10-31 | 2016-10-31 | 2015-10-31 | 2014-10-31 | 2013-10-31 | 2012-10-31 | 2011-10-31 |
| Operating Activities | |||||||||||||||
| Net Income | -$5.52M | -$4.71M | -$6.99M | -$8.9M | -$12.76M | -$12.58M | -$1.74M | -$3.46M | -$8.97M | -$1.25M | -$738K | -$66K | -$32K | -$12K | -$12K |
| Depreciation & Amortization | $73K | $74K | $486K | $333K | $53K | $37K | $15K | $8K | $19K | $345 | $86 | $0 | $0 | $0 | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $4.69M | $3.85M | $3.21M | $3.92M | $8.65M | $9.91M | $727K | $4.02M | $5.82M | $0 | $268K | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | |||||||||||||||
| Accounts Receivable | $162K | -$176K | $20K | -$119K | -$75K | -$4K | $11K | $5K | -$119K | $18K | $45K | $2K | -$9K | -$17K | -$13K |
| Inventory | -$191K | $78K | -$62K | -$51K | -$88K | -$69K | -$78K | $60K | -$110K | -$10K | -$2K | $6K | -$297 | -$8K | -$9K |
| Accounts Payable | $200K | -$851K | $233K | $1.04M | $1.15M | $219K | $76K | $65K | $343K | $5K | $9K | -$19K | $10K | $11K | $7K |
| Other Working Capital | -$311K | $421K | $599K | $529K | $385K | $554K | -$461K | $2.24M | -$2.9M | -$816K | -$14K | -$52K | $11K | $0 | $13K |
| Total Working Capital Change | -$140K | -$528K | $790K | $1.39M | $1.37M | $701K | -$452K | $2.37M | -$2.78M | -$802K | $39K | -$64K | $11K | -$13K | -$1K |
| Other Non-Cash Items | $177K | -$144K | $305K | $87K | $0 | $119K | $882K | -$3.46M | $5.03M | $1.51M | $47K | $65K | -$9K | $17K | $0 |
| Net Cash from Operating | -$718K | -$1.45M | -$2.2M | -$3.17M | -$2.68M | -$1.81M | -$565K | -$512K | -$882K | -$548K | -$385K | -$65K | -$30K | -$9K | -$13K |
| Investing Activities | |||||||||||||||
| Capital Expenditures | -$23K | $0 | -$26K | -$825K | -$425K | -$139K | -$32.74B | -$5K | -$45K | -$26K | -$8K | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $100K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | -$45K | -$100K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $741K | $0 | $0 | $0 | $32.74B | $0 | $0 | $6K | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$23K | -$45K | $615K | -$825K | -$425K | -$139K | -$33K | $95K | -$45K | -$20K | -$8K | $0 | $0 | $0 | $0 |
| Financing Activities | |||||||||||||||
| Debt Repaid | $45K | $24K | $115K | -$115K | $84K | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $350K | $500K | $100K | $7.27M | $2.71M | $2.2M | $460K | $100K | $505K | $457K | $496K | $0 | $42K | $0 | $25K |
| Common Stock Repurchases | $0 | -$80K | -$500K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $250K | $0 | $2.41M | $688K | $420K | $940K | $557K | $492K | $47K | $42K | $0 | $25K |
| Net Cash from Financing | $305K | $396K | -$415K | $7.64M | $2.62M | $2.41M | $688K | $420K | $940K | $557K | $492K | $47K | $42K | $0 | $25K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2K | $2K | -$997 | $0 |
| Net Change in Cash | -$436K | -$1.1M | -$2M | $3.64M | -$482K | $458K | $90K | $3K | $13K | -$11K | $99K | -$16K | $14K | -$10K | $12K |
| Supplementary Data | |||||||||||||||
| Operating Cash Flow | -$718K | -$1.45M | -$2.2M | -$3.17M | -$2.68M | -$1.81M | -$565K | -$512K | -$882K | -$548K | -$385K | -$65K | -$30K | -$9K | -$13K |
| Capital Expenditure | -$23K | $0 | -$26K | -$825K | -$425K | -$139K | -$32.74B | -$5K | -$45K | -$26K | -$8K | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$741K | -$1.45M | -$2.22M | -$3.99M | -$3.11M | -$1.95M | -$32.74B | -$517K | -$927K | -$575K | -$393K | -$65K | -$30K | -$9K | -$13K |
| Cash at Beginning | $657K | $1.76M | $3.75M | $109K | $591K | $133K | $43K | $40K | $26K | $38K | $244 | $16K | $2K | $12K | $0 |
| Cash at End | $221K | $657K | $1.76M | $3.75M | $109K | $591K | $133K | $43K | $40K | $26K | $99K | $244 | $16K | $2K | $12K |